Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mantle cell lymphomas

M A Rodriguez1, W C Pugh

  • 1Department of Hematology, U.T.M.D. Anderson Cancer Center, Houston 77030, USA.

Cancer Treatment and Research
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Mantle cell lymphoma (MCL) presents differently based on its histologic pattern. Diffuse MCL shows poor chemotherapy response, while mantle zone MCL has excellent remission rates, impacting survival outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bioactive Glasses as Alternatives to Hydroxyapatite for Bone Implant Coatings: A Comparative Study.

Journal of biomedical materials research. Part B, Applied biomaterials·2025
Same author

Inhibiting NCX delays the early onset of Ca<sup>2+</sup> alternans in myocytes from spontaneously hypertensive rats (SHR).

Journal of molecular and cellular cardiology·2025
Same author

Uric acid and acute kidney injury in high-risk patients for developing acute kidney injury undergoing cardiac surgery: A prospective multicenter study.

Revista espanola de anestesiologia y reanimacion·2024
Same author

Open-source, low-cost App-driven Internet of Things approach to facilitate respiratory oscillometry at home and in developing countries.

Pulmonology·2023
Same author

External validation of Fetal Medicine Foundation competing-risks model for midgestation prediction of small-for-gestational-age neonates in Spanish population.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2023
Same author

Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study.

Langenbeck's archives of surgery·2022
Same journal

Clinical Trials and Translational Advances in Metabolic Targeting.

Cancer treatment and research·2026
Same journal

Tools and Technologies for Studying Cancer Metabolism.

Cancer treatment and research·2026
Same journal

Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.

Cancer treatment and research·2026
Same journal

Biomarkers of Cancer Metabolism and Therapeutic Response.

Cancer treatment and research·2026
Same journal

Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.

Cancer treatment and research·2026
Same journal

Metabolic Reprogramming in Cancer Stem Cells.

Cancer treatment and research·2026
See all related articles

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Mantle cell lymphoma (MCL) originates from CD5-expressing B cells in lymphoid follicles.
  • MCL is distinct from small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL), notably differing in cytogenetic abnormalities (translocation 11;14 in MCL vs. trisomy 12 in SLL/CLL).

Purpose of the Study:

  • To investigate the correlation between histologic patterns of MCL and clinical outcomes.
  • To evaluate the therapeutic response to chemotherapy based on MCL subtypes.

Main Methods:

  • Analysis of histologic patterns in lymph nodes (diffuse, mantle zone, nodular).
  • Correlation of these patterns with clinical presentation, disease stage, extranodal involvement, and response to frontline chemotherapy (including doxorubicin).

Related Experiment Videos

Main Results:

  • Diffuse MCL typically presents at advanced stages and shows poor response to standard chemotherapy.
  • Mantle zone MCL exhibits excellent complete remission rates with frontline chemotherapy.
  • Nodular MCL demonstrates clinical behavior similar to diffuse MCL, with poor chemotherapeutic response.

Conclusions:

  • Histologic pattern significantly correlates with clinical outcome and therapeutic response in MCL.
  • Diffuse and nodular MCL subtypes require novel investigational approaches for frontline therapy due to poor response to current regimens.
  • Mantle zone MCL patients achieve better outcomes compared to diffuse MCL patients.